Jiangzhong Pharmaceutical Co Ltd (600750) — Cash Flow Reinvestment Rate
Jiangzhong Pharmaceutical Co Ltd (600750) has a Cash Flow Reinvestment Rate of 0.29x as of September 2025, reinvesting CN¥95.46 Million (capex CN¥95.46 Million ) from operating cash flow of CN¥326.81 Million. Explore Jiangzhong Pharmaceutical Co Ltd (600750) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangzhong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Jiangzhong Pharmaceutical Co Ltd across 26 annual periods. Also explore 600750 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jiangzhong Pharmaceutical Co Ltd (2000–2025)
Year-by-year capital reinvestment analysis for Jiangzhong Pharmaceutical Co Ltd. For live market cap and broader valuation context, see how much is Jiangzhong Pharmaceutical Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥377.57 Million | CN¥970.87 Million | CN¥280.57 Million | ▼ -49.0% |
| 2024 | 0.76x | CN¥599.39 Million | CN¥786.25 Million | CN¥290.77 Million | ▲ +135.1% |
| 2023 | 0.32x | CN¥335.91 Million | CN¥1.04 Billion | CN¥208.88 Million | ▼ -53.8% |
| 2022 | 0.70x | CN¥716.51 Million | CN¥1.02 Billion | CN¥345.64 Million | ▼ -57.0% |
| 2021 | 1.63x | CN¥1.50 Billion | CN¥917.04 Million | CN¥188.49 Million | ▲ +78.3% |
| 2020 | 0.92x | CN¥688.96 Million | CN¥752.50 Million | CN¥182.53 Million | ▼ -12.0% |
| 2019 | 1.04x | CN¥666.99 Million | CN¥641.18 Million | CN¥76.33 Million | ▲ +206.4% |
| 2018 | 0.34x | CN¥165.10 Million | CN¥486.25 Million | CN¥121.38 Million | ▼ -80.8% |
| 2017 | 1.77x | CN¥221.21 Million | CN¥124.93 Million | CN¥181.21 Million | ▲ +1582.0% |
| 2016 | 0.11x | CN¥73.49 Million | CN¥698.05 Million | CN¥70.07 Million | ▼ -69.7% |
| 2015 | 0.35x | CN¥177.25 Million | CN¥510.78 Million | CN¥62.75 Million | ▲ +21.0% |
| 2014 | 0.29x | CN¥102.33 Million | CN¥356.80 Million | CN¥102.33 Million | ▼ -50.3% |
| 2013 | 0.58x | CN¥64.59 Million | CN¥111.92 Million | CN¥64.59 Million | ▼ -41.8% |
| 2012 | 0.99x | CN¥224.42 Million | CN¥226.38 Million | CN¥224.42 Million | ▼ -32.6% |
| 2011 | 1.47x | CN¥247.55 Million | CN¥168.30 Million | CN¥247.55 Million | ▲ +132.1% |
| 2010 | 0.63x | CN¥140.86 Million | CN¥222.29 Million | CN¥140.86 Million | ▲ +1138.0% |
| 2009 | 0.05x | CN¥19.37 Million | CN¥378.32 Million | CN¥19.37 Million | ▼ -32.8% |
| 2008 | 0.08x | CN¥20.49 Million | CN¥268.87 Million | CN¥20.49 Million | ▲ +4.9% |
| 2007 | 0.07x | CN¥11.16 Million | CN¥153.63 Million | CN¥11.16 Million | ▼ -86.9% |
| 2006 | 0.56x | CN¥30.69 Million | CN¥55.24 Million | CN¥30.69 Million | ▲ +68.5% |
| 2005 | 0.33x | CN¥65.42 Million | CN¥198.45 Million | CN¥65.42 Million | ▼ -96.7% |
| 2004 | 10.01x | CN¥263.03 Million | CN¥26.28 Million | CN¥263.03 Million | ▲ +241.5% |
| 2003 | 2.93x | CN¥231.42 Million | CN¥78.98 Million | CN¥231.42 Million | ▲ +141.0% |
| 2002 | 1.22x | CN¥115.40 Million | CN¥94.90 Million | CN¥115.40 Million | ▲ +892.2% |
| 2001 | 0.12x | CN¥5.06 Million | CN¥41.28 Million | CN¥5.06 Million | ▼ -45.2% |
| 2000 | 0.22x | CN¥27.22 Million | CN¥121.77 Million | CN¥27.22 Million | — |